A metabolic disorder characterized by abnormally high blood sugar levels due to diminished production of insulin or insulin resistance/desensitization.
Comprehensive, easy-to-understand information about this condition
How we create this content →Connect with organizations supporting the diabetes mellitus community
Helpful links for rare disease information and support
Questions that may be helpful when speaking with your healthcare team
Connect with organizations supporting the diabetes mellitus community
Helpful links for rare disease information and support
Questions that may be helpful when speaking with your healthcare team
Connect with organizations supporting the diabetes mellitus community
Helpful links for rare disease information and support
Questions that may be helpful when speaking with your healthcare team
Research studies investigating treatments and therapies for this condition.
Active Trials
Total Trials
Data from ClinicalTrials.gov Feb 1, 2026
Patient Advocacy Groups (PAGs) provide support, resources, and community for patients and caregivers.
AI-Generated Content: This summary was generated using AI. Content has been fact-checked. Always consult with qualified healthcare providers for medical guidance.
Kisho delivers this disease record via API, including phenotypes (HPO), genes, orphan drug designations, screening status, and PAG mapping, with version history and governance.
AI-curated news mentioning diabetes mellitus
Updated Feb 2, 2026
Novo Nordisk's CagriSema demonstrates superior blood sugar and weight reduction compared to Wegovy in a recent diabetes trial. However, it may face challenges competing against Eli Lilly's Zepbound in the obesity market.
The CDC has released the latest National Diabetes Statistics Report, providing updated statistics on diabetes prevalence and impact. This periodic publication is crucial for informing health policy and resource allocation.
A CDC study reveals that young people with diabetes incur annual medical costs of $9,061, significantly higher than the $1,468 for their peers without the disease. This highlights the financial burden faced by families managing diabetes in youth.
New estimates reveal that nearly 26 million Americans have diabetes, with an additional 79 million adults classified as having prediabetes. This significant prevalence underscores the urgent need for awareness and intervention strategies to combat diabetes and its associated risks.
A new analysis projects that by 2050, up to 1 in 3 U.S. adults could be affected by diabetes if current trends persist. This alarming statistic highlights the urgent need for awareness and intervention strategies.